MetLife Investment Management LLC Grows Stock Holdings in HealthEquity, Inc. (NASDAQ:HQY)

MetLife Investment Management LLC lifted its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 8.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 99,019 shares of the company’s stock after purchasing an additional 7,618 shares during the period. MetLife Investment Management LLC owned 0.11% of HealthEquity worth $9,501,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of HQY. Arcadia Investment Management Corp MI purchased a new stake in HealthEquity in the 4th quarter worth approximately $26,000. Smartleaf Asset Management LLC raised its holdings in shares of HealthEquity by 34.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock valued at $37,000 after acquiring an additional 98 shares in the last quarter. UMB Bank n.a. lifted its stake in HealthEquity by 65.6% in the fourth quarter. UMB Bank n.a. now owns 414 shares of the company’s stock worth $40,000 after acquiring an additional 164 shares during the period. Skandinaviska Enskilda Banken AB publ boosted its holdings in HealthEquity by 1,934.8% in the fourth quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company’s stock valued at $45,000 after acquiring an additional 445 shares in the last quarter. Finally, Lindbrook Capital LLC raised its holdings in HealthEquity by 27.6% in the 4th quarter. Lindbrook Capital LLC now owns 750 shares of the company’s stock worth $72,000 after purchasing an additional 162 shares in the last quarter. 99.55% of the stock is owned by institutional investors.

HealthEquity Stock Down 5.1 %

HQY stock opened at $80.20 on Tuesday. The stock has a market capitalization of $6.94 billion, a P/E ratio of 73.58, a P/E/G ratio of 1.60 and a beta of 0.49. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. HealthEquity, Inc. has a 1-year low of $65.01 and a 1-year high of $115.59. The business has a fifty day moving average price of $94.09 and a 200-day moving average price of $96.53.

Insider Buying and Selling at HealthEquity

In related news, Director Robert W. Selander sold 5,750 shares of the company’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the sale, the director now owns 78,219 shares in the company, valued at approximately $8,704,992.51. This represents a 6.85 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Michael Henry Fiore sold 8,881 shares of the business’s stock in a transaction dated Friday, April 4th. The shares were sold at an average price of $78.26, for a total value of $695,027.06. Following the sale, the executive vice president now owns 56,655 shares of the company’s stock, valued at approximately $4,433,820.30. This represents a 13.55 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 20,381 shares of company stock worth $1,781,432. Company insiders own 2.20% of the company’s stock.

Analyst Ratings Changes

HQY has been the subject of a number of research reports. KeyCorp decreased their price target on shares of HealthEquity from $110.00 to $100.00 and set an “overweight” rating for the company in a research note on Wednesday, April 16th. The Goldman Sachs Group lowered their target price on HealthEquity from $107.00 to $94.00 and set a “neutral” rating for the company in a research note on Thursday, March 27th. Barrington Research reaffirmed an “outperform” rating and issued a $112.00 price target on shares of HealthEquity in a research note on Friday, April 11th. Wells Fargo & Company increased their price objective on HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a report on Wednesday, February 26th. Finally, Raymond James upgraded shares of HealthEquity from an “outperform” rating to a “strong-buy” rating and dropped their target price for the company from $120.00 to $115.00 in a report on Tuesday, March 25th. One equities research analyst has rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Buy” and an average target price of $111.75.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.